Single cell multi-omic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma

被引：0

作者：

Harrison, Simon ^{[1
,2
]}

Riley, Caroline Hasselbalch ^{[3
]}

Manier, Salomon ^{[4
]}

Yoon, Sung-Soo ^{[5
]}

Pinto, Antonio ^{[6
]}

Cazaubiel, Titouan ^{[7
]}

Guidetti, Anna ^{[8
]}

Popat, Rakesh ^{[9
]}

Touzeau, Cyrille ^{[10
]}

Ocio, Enrique ^{[11
]}

Offner, Fritz ^{[12
]}

Rodriguez-Otero, Paula ^{[13
]}

Rizzello, Ilaria ^{[14
,15
]}

Mateos, Maria-Victoria ^{[16
]}

Broeske, Ann-Marie ^{[17
]}

Dekhtiarenko, Iryna ^{[18
]}

Dimier, Natalie ^{[19
]}

Eckmann, Jan ^{[17
]}

Helms, Hans-Joachin ^{[20
]}

Jacob, Wolfgang ^{[17
]}

Schneider, Meike ^{[20
]}

Sleiman, Nassim ^{[20
]}

Weisser, Martin ^{[17
]}

Carlo-Stella, Carmelo ^{[21
,22
]}

机构：

[1] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[2] Univ Melbourne, Royal Melbourne Hosp, Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[3] Rigshospitalet, Copenhagen, Denmark

[4] CHU Lille, Lille, France

[5] Seoul Natl Univ, Coll Med, Seoul, South Korea

[6] Ist Nazl Tumori IRCCS Fondazione G Pascale, Naples, Italy

[7] CHU Bordeaux, Bordeaux, France

[8] Ist Nazl Tumori, Milan, Italy

[9] NHS Univ Coll London Hosp, London, England

[10] CHU Nantes, Nantes, France

[11] Marques Valdecilla Univ Hosp, Santander, Spain

[12] Univ Ziekenhuis Gent, Ghent, Belgium

[13] Clin Univ Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain

[14] Univ Bologna, Ist Ematol Seragnoli, IRCCS Azienda Osped, Bologna, Italy

[15] Univ Bologna, Bologna, Italy

[16] Univ Hosp Salamanca, IBSAL, CIC, CIBERONC, Salamanca, Spain

[17] Roche Innovat Ctr Munich, Penzberg, Germany

[18] Roche Innovat Ctr Zurich, Zurich, Switzerland

[19] Roche Innovat Ctr Welwyn, Welwyn Garden City, England

[20] Roche Innovat Ctr Basel, Basel, Switzerland

[21] Humanitas Univ, Dept Oncol & Hematol, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy

[22] Humanitas Univ, Dept Biomed Sci, Rozzano, Italy

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA-04

引用

页码：S3 / S3

页数：1

共 50 条

[1] Single Cell Multi-Omic Dissection of Response and Resistance to Chimeric Antigen Receptor T Cells Against BCMA in Relapsed Multiple Myeloma
Merz, Maximilian
Fischer, Luise
Sia, Jaren
Born, Patrick
Weiss, Ronald
Grieb, Nora
Rade, Michael
Boldt, Andreas
Fricke, Stephan
Franz, Paul
Scolnick, Jonathan
Venkatraman, Lakshmi
Xu, Stacy
Kloetzer, Christina
Heyn, Simone
Kubasch, Anne Sophie
Baber, Ronny
Wang, Song Yau
Bach, Enrica
Hoffmann, Sandra
Ussmann, Jule
Metzeler, Klaus H.
Herling, Marco
Herling, Carmen
Jentzsch, Madlen
Franke, Georg-Nikolaus
Sack, Ulrich
Koehl, Ulrike
Reiche, Kristin
Platzbecker, Uwe
Vucinic, Vladan
BLOOD, 2023, 142
[2] Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma
Rade, Michael
Grieb, Nora
Weiss, Ronald
Sia, Jaren
Fischer, Luise
Born, Patrick
Boldt, Andreas
Fricke, Stephan
Franz, Paul
Scolnick, Jonathan
Venkatraman, Lakshmi
Xu, Stacy
Kloetzer, Christina
Heyn, Simone
Kubasch, Anne Sophie
Baber, Ronny
Wang, Song Yau
Bach, Enrica
Hoffmann, Sandra
Ussmann, Jule
Schetschorke, Birthe
Hell, Saskia
Schwind, Sebastian
Metzeler, Klaus H.
Herling, Marco
Jentzsch, Madlen
Franke, Georg-Nikolaus
Sack, Ulrich
Koehl, Ulrike
Platzbecker, Uwe
Reiche, Kristin
Vucinic, Vladan
Merz, Maximilian
NATURE CANCER, 2024, 5 (09) : 1318 - 1333
[3] BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma
Fang, Jiamin
Zhou, Fuling
ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1069 - 1083
[4] Lenalidomide Enhances Anti-BCMA Chimeric Antigen Receptor T Cell Function Against Multiple Myeloma
Works, Melissa
Soni, Neha
Hauskins, Collin
Sierra, Catherine
Baturevych, Alex
Jones, Jon
Curtis, Wendy
Johnstone, Timothy
Kugler, David
Jiang, Yue
Hause, Ron
Sather, Blythe Duke
Salmon, Ruth
Ports, Michael
BLOOD, 2017, 130
[5] Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Yamamoto, Chihiro
Minakata, Daisuke
Yokoyama, Daizo
Furuki, Shuka
Noguchi, Atsuto
Koyama, Shunsuke
Oyama, Takashi
Murahashi, Rui
Nakashima, Hirotomo
Ikeda, Takashi
Kawaguchi, Shin-ichiro
Hyodo, Kazuki
Toda, Yumiko
Ito, Shoko
Nagayama, Takashi
Umino, Kento
Morita, Kaoru
Ashizawa, Masahiro
Ueda, Masuzu
Hatano, Kaoru
Sato, Kazuya
Ohmine, Ken
Fujiwara, Shin-ichiro
Kanda, Yoshinobu
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 118.e1 - 118.e15
[6] BCMA-targeting chimeric antigen receptor T-cell therapy for multiple myeloma
Yang, Jinrong
Zhou, Weilin
Li, Dan
Niu, Ting
Wang, Wei
CANCER LETTERS, 2023, 553
[7] Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma
Yang, Xu
Wang, Feiqing
Yuan, Xiaoshuang
Yang, Bo
Chen, Juan
Cheng, Jinyang
Liu, Guangyang
Tang, Dongxin
Xu, Xiao
Wang, Sanbin
He, Zhixu
Liu, Yang
Li, Yanju
FRONTIERS IN IMMUNOLOGY, 2024, 15
[8] HBI0101, an Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for Relapsed/Refractory Multiple Myeloma
Lebel, Eyal
Asherie, Nathalie
Kfir-Erenfeld, Shlomit
Grisariu, Sigal
Avni, Batia
Elias, Shlomo
Assayag, Miri
Dubnikov-Sharon, Tali
Zimran, Eran
Shaulov, Adir
Pick, Marjorie
Cohen, Cyrille
Stepensky, Polina
Gatt, Moshe
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S22 - S22
[9] Chimeric Antigen Receptor T Cells in Multiple Myeloma
Shah, Parth
Sperling, Adam S.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1089 - 1105
[10] MECHANISMS OF RESISTANCE TO CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IN MULTIPLE MYELOMA
Camviel, N.
Wolf, B.
Croce, G.
Gfeller, D.
Zoete, V.
Arber, C.
HUMAN GENE THERAPY, 2022, 33 (7-8) : A12 - A13

← 1 2 3 4 5 →